600211.SS
Price:
$36.08
Market Cap:
$11.63B
Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1999-07-21
Stock Exchange
SHH
Ticker
600211.SS
According to Tibet Rhodiola Pharmaceutical Holding Co.’s latest financial reports and current stock price. The company's current PE Ratio is 11.45. This represents a change of -9.84% compared to the average of 12.70 of the last 4 quarters.
The mean historical PE Ratio of Tibet Rhodiola Pharmaceutical Holding Co. over the last ten years is 25.90. The current 11.45 PE Ratio has changed 4.32% with respect to the historical average. Over the past ten years (40 quarters), 600211.SS's PE Ratio was at its highest in in the June 2017 quarter at 303.21. The PE Ratio was at its lowest in in the December 2018 quarter at -63.81.
Average
25.90
Median
18.77
Minimum
11.33
Maximum
53.44
Discovering the peaks and valleys of Tibet Rhodiola Pharmaceutical Holding Co. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 118.21%
Maximum Annual PE Ratio = 53.44
Minimum Annual Increase = -73.30%
Minimum Annual PE Ratio = 11.33
Year | PE Ratio | Change |
---|---|---|
2024 | 11.33 | -25.52% |
2023 | 15.21 | -17.87% |
2022 | 18.52 | -61.25% |
2021 | 47.80 | 55.75% |
2020 | 30.69 | 118.21% |
2019 | 14.06 | -23.44% |
2018 | 18.37 | -3.40% |
2017 | 19.02 | -37.84% |
2016 | 30.59 | -42.76% |
2015 | 53.44 | -73.30% |
The current PE Ratio of Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
15.02
5-year avg
24.71
10-year avg
25.90
Tibet Rhodiola Pharmaceutical Holding Co.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tibet Rhodiola Pharmaceutical Holding Co. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tibet Rhodiola Pharmaceutical Holding Co. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Tibet Rhodiola Pharmaceutical Holding Co.'s PE Ratio?
How is the PE Ratio calculated for Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)?
What is the highest PE Ratio for Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)?
What is the 3-year average PE Ratio for Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)?
What is the 5-year average PE Ratio for Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)?
How does the current PE Ratio for Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) compare to its historical average?